retatrutide parkinson disease clinical trial Update on retatrutide parkinson trial nct Retatrutide
Description
Pharma Now has not independently verified all claims in the underlying reporting.
Over 12 months, the liraglutide group also reported an 18% slower decline in cognitive function when compared with the placebo group in the study
Physiology & Behavior, 276 , 114474
The obesity trial included individuals with body mass index (BMI) between 27 and 30 kg m- and at least one weight-related condition, as well as individuals with BMI 30 kg m-
Switches are coordinated through your clinician with clear tapering and initiation protocols
